Rawan G Faramand

11PUBLICATIONS
106CO-AUTHORS
PhysiotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 25, 2026
Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

|Jun 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD prevention.

|Feb 05, 2026
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Dec 12, 2025
Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial.

Everett H Meyer, Amandeep Salhotra, Arpita P Gandhi

|Oct 06, 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia.

Yannis K Valtis, Chenyu Lin, David Nemirovsky

|May 07, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy.

Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem

Pageof 2

Frequent Collaborators

4 joint publications

Bijal D Shah

3 joint publications

Kaitlyn C Dykes

3 joint publications

Taiga Nishihori

3 joint publications

Noelle V Frey